Kevin D. Brandt

2019 - Xtant Medical Holdings

In 2019, Kevin D. Brandt earned a total compensation of $812.3K as Chief Commercial Officer at Xtant Medical Holdings, a 22% increase compared to previous year.

Compensation breakdown

Bonus$90,000
Non-Equity Incentive Plan$124,125
Option Awards$85,546
Salary$398,113
Stock Awards$97,066
Other$17,416
Total$812,266

Brandt received $398.1K in salary, accounting for 49% of the total pay in 2019.

Brandt also received $90K in bonus, $124.1K in non-equity incentive plan, $85.5K in option awards, $97.1K in stock awards and $17.4K in other compensation.

Rankings

In 2019, Kevin D. Brandt's compensation ranked 10,150th out of 13,971 executives tracked by ExecPay. In other words, Brandt earned more than 27.3% of executives.

ClassificationRankingPercentile
All
10,150
out of 13,971
27th
Division
Manufacturing
4,106
out of 5,701
28th
Major group
Chemicals And Allied Products
1,566
out of 2,200
29th
Industry group
Drugs
1,341
out of 1,886
29th
Industry
Biological Products, Except Diagnostic Substances
294
out of 389
24th
Source: SEC filing on June 14, 2021.

Brandt's colleagues

We found two more compensation records of executives who worked with Kevin D. Brandt at Xtant Medical Holdings in 2019.

2019

Sean Browne

Xtant Medical Holdings

Chief Executive Officer

2019

Greg Jensen

Xtant Medical Holdings

Chief Financial Officer

News

You may also like